What are the opening hours?

Monday 8:30am - 5:30pm Tuesday 8:30am - 5:30pm Wednesday 8:30am - 5:30pm Thursday 8:30am - 5:30pm Friday 8:30am - 5:30pm

Synbio Technologies

Name: Synbio Technologies
Address: 9 Deer Park Drive , Suite J-25, Monmouth Junction, NJ, 08852, US
Telephone: +17322303003
Price range: $

Empowering scientific discoveries with advanced DNA manufacturing and design solutions.

Synbio Technologies was founded in August of 2013 with the hopes of becoming one of the premier companies within the synthetic biology industry. In order to accomplish this goal, many hurdles were circumvented to continue to move forward and offer our customers the highest quality product possible. By striving to move forward in this industry we have fine-tuned our mechanisms of various synthetic

biological applications and continue to do so on a daily basis. This is because we strive to be on the cutting edge of this technology which has led us to make groundbreaking discoveries within this field. In doing so we have developed the world’s first GPS Platform, including genotype, phenotype and synotype. The GPS Platform is what separates us from the rest of the competition within this industry. This platform is broken down into three portions and when combined offers a one stop solution of gene “design-construction-application” process. This streamlined process allows us to offer our customers a unique experience when designing their gene of interest in order to comply with the research interests. In addition to our technologically advanced synthetic biology applications there are hundreds of professionals with experienced track records of success in scientific research and industrial management. We are proud to have such a devoted staff with one goal in mind: to offer our customers with the highest quality product possible within an efficient time-frame. Our staff has perfected and streamlined many of these biological applications in order to comply with our customer’s demands. Please contact us with any questions you may have about our various services that we are currently offering.

06/23/2026

Peptide libraries are widely used in oncology, immunology, and proteomics to explore bioactive sequence space at scale.

Key trends include:
🔬 AI-assisted screening improving hit identification efficiency
💊 Growing interest in macrocyclic peptides for their stability and binding specificity
🛡️ Continued reliance on peptide-level resolution in immunotherapy and vaccine research

Library quality remains a key factor influencing downstream screening performance.

We support large-scale peptide library synthesis with flexible purity options (crude to 99%), fully QC-verified by HPLC, MS, and COA documentation.
https://hubs.la/Q04mgyCm0

06/22/2026

🧬 Collagen gene synthesis often runs into challenges due to long Gly–X–Y repeats. These repetitive sequences can lead to misalignments, unstable secondary structures, and reduced assembly efficiency.

In practice, this can slow down construct design and impact downstream expression.

At Synbio Technologies, we support collagen-related gene design with:
• Sequence optimization tailored for repetitive regions
• Flexible cloning strategies in E. coli systems
• Iterative construct testing to evaluate design performance early

These approaches can help improve expression consistency and downstream usability across applications such as skincare research, regenerative medicine, and biomaterials development.
https://hubs.la/Q04m77pH0

06/19/2026

🧬 Every breakthrough starts with a question.

Today, on World Sickle Cell Day, we recognize the scientists, clinicians, patients, and families driving progress in sickle cell disease research.

Gene editing is opening new possibilities for understanding genetic disorders and developing innovative therapeutic strategies. Continued research is helping move the field forward—one discovery at a time.

🎉 June Research Offer: Edit 6 genes, pay for 5.
https://hubs.la/Q04lQcCQ0

06/18/2026

🧬 A promising advance in precision oncology.

Researchers from of Utah and collaborators engineered a CRISPR-Cas12a2 system that detects mutation-specific RNA and selectively destroys cancer cells while sparing healthy cells.

🔬 Highly specific targeting
🎯 Potential to address difficult-to-treat mutations
🧩 Future applications may extend beyond cancer

Learn more about gene editing technologies:
👉 https://hubs.la/Q04lQ1z50

06/17/2026

🧬 Exploring larger libraries and broader sequence diversity in your next project?

Oligo pools have become an important tool for applications ranging from functional genomics to synthetic biology, helping researchers generate and test thousands of variants in parallel.

Common applications include:
🔬 CRISPR screening libraries
🧪 Deep mutational scanning
⚙️ Pathway engineering and optimization
💊 Drug discovery and antibody engineering

Designed for high complexity, high fidelity, and scalable workflows, oligo pools can help streamline library construction while supporting large-scale screening efforts.

🎉 For a limited time, Oligo Pool Synthesis is available at 50% off.
https://hubs.la/Q04lGY6F0

06/16/2026

🧬 One Oligo Pool. Many Research Possibilities.

Custom oligo pools are becoming a versatile tool for modern genomics workflows.

Instead of dedicating an entire pool to a single library, researchers can generate multiple focused screening libraries from the same starting material—enabling different biological questions to be explored in parallel.

🔹 Investigate specific pathways
🔹 Study targeted gene families
🔹 Support multiple screening strategies
🔹 Make better use of valuable research resources

From functional genomics to library construction and molecular tracking, oligo pools continue to expand what's possible in large-scale biological research.

👇 What applications are you currently exploring with oligo pools?
https://hubs.la/Q04lx0s20

06/15/2026

🩸❤️ World Blood Donor Day

A single blood donation can help patients facing surgery, cancer treatment, trauma, and many other medical needs.

Today, we celebrate the donors whose generosity supports communities every day and helps ensure lifesaving care is available when it's needed most.

Together, small acts of kindness can make a meaningful impact.

06/12/2026

🔬 What happens after a successful hybridoma is generated?

For many antibody programs, the next critical step is identifying the antibody sequence. 🧬

Sequence information can help enable:

✨ Recombinant antibody production
✨ Humanization and engineering
✨ Intellectual property protection
✨ Consistent research outcomes

Our latest blog discusses why hybridoma sequencing has become an important part of modern antibody development and reviews several commonly used sequencing strategies.

📖 Learn more: https://hubs.la/Q04l9d7-0

06/11/2026

🧬 From AI De Novo Design to Affinity Maturation: One Connected Antibody Discovery Workflow

Antibody discovery programs often involve multiple platforms, teams, and handoffs—each adding complexity, timelines, and potential project risk.

Our integrated antibody discovery workflow supports every stage of development:
✔️ AI De Novo Design – Generate fully humanized antibody candidates using advanced computational modeling
✔️ Hybridoma & Single B Cell Discovery – Move efficiently from immunization to sequence identification
✔️ Optimization & Expression – Affinity maturation, humanization, recombinant expression, and QC under one workflow

Whether you're starting with a target, an immunized animal, or a candidate sequence, a connected platform can help reduce transitions and accelerate decision-making.
https://hubs.la/Q04l0Hw40

06/10/2026

🧬 AAV Safety: New Questions for the Gene Therapy Field

A case discussed at highlighted the possibility that AAV vector integration may have played a role in a pediatric gene therapy patient's adverse outcome.

While such events appear to be extremely rare, findings like these help advance our understanding of vector biology and long-term safety.

Some questions researchers are continuing to explore:
🔹 How can integration risk be further reduced?
🔹 Could tissue-specific promoter design improve safety profiles?
🔹 What role might long-read sequencing play in long-term monitoring?

As gene therapies continue to evolve, ongoing research and transparent discussion remain essential to improving future treatments.
https://hubs.la/Q04kQKfF0

Address

9 Deer Park Drive , Suite J-25
Monmouth Junction, NJ
08852

Opening Hours

Monday	8:30am - 5:30pm
Tuesday	8:30am - 5:30pm
Wednesday	8:30am - 5:30pm
Thursday	8:30am - 5:30pm
Friday	8:30am - 5:30pm

Telephone

+17322303003

Website

http://www.synbio-tech.com/

Alerts

Be the first to know and let us send you an email when Synbio Technologies posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Synbio Technologies:

Shortcuts

Address
Telephone
Opening Hours
Alerts
Contact The Business
Claim ownership or report listing

Want your business to be the top-listed Engineering Company in Monmouth Junction?